Stocks Merck & Co Inc

More

  • What's behind skyrocketing drug prices Monday, 21 Dec 2015 | 1:37 PM ET
    Martin Shkreli.

    The latest drug-price increases are just the tip of the iceberg, explains former Medtronic CEO Bill George.

  • *Zoetis, Pfizer assets could attract Bayer in future. Possible targets for the German company could include veterinary drug firm Zoetis and Pfizer's consumer health business, the two sources said. Bayer, Zoetis and Pfizer declined to comment.

  • Fed's rate hike sparks rally in unlikely group Thursday, 17 Dec 2015 | 12:05 AM ET
    Stock Market Rise

    The Fed's decision Wednesday to increase interest rates for the first time since June 2006 sparked a rally in an unlikely group of stocks.

  • Dow closes up more than 200 after Fed hikes rates Wednesday, 16 Dec 2015 | 4:00 PM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed higher after the Federal Reserve raised rates for the first time in nearly a decade. Only the energy sector lagged as oil prices resumed their decline.

  • Dec 16- Drug developer Advaxis Inc said on Wednesday the U.S. Food and Drug Administration had lifted a clinical hold on three of its experimental cancer therapies, sending the company's shares up as much as 38 percent. Advaxis had then said the patient died due to progression of cervical cancer and that the drug played no role in the death. Advaxis said on...

  • Early movers: GE, SIRI, MMM, FEYE, COH, V, BA & more Tuesday, 15 Dec 2015 | 8:10 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Wall Street aims for 2-day rally as Fed meeting begins Tuesday, 15 Dec 2015 | 7:28 AM ET

    U.S. stock futures were sharply higher this morning, after Monday's strong gains on Wall Street.

  • WASHINGTON, Dec 15- President Barack Obama, who made few friends in corporate board rooms early in his first term as he pressed for tighter regulations on banks and remarked on the "fat cats" who helped precipitate the financial crisis, heads into his final year in the White House having built- or rebuilt- alliances with chief executives of the nation's biggest...

  • Your first trade for Tuesday Monday, 14 Dec 2015 | 6:25 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Dec 14- Merck& Co should not be allowed to claim that its cholesterol-lowering drug Vytorin reduces the risk of heart attacks and strokes in patients with coronary heart disease, an advisory committee to the U.S. Food and Drug Administration concluded on Monday. Milton Packer, distinguished scholar in cardiovascular science at Baylor University Medical...

  • Dec 14- Animal-nutritionist John Goihl knows Minnesota farmers who feed the remains of dead baby pigs to hogs used for breeding in attempts to ward off infections of a deadly virus in offspring. A resurgence could drive up prices again and hurt profits for processors including Tyson Foods and JBS USA, which have benefited from low hog prices.

  • Stocks close lower as oil drags down energy Monday, 7 Dec 2015 | 4:00 PM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed lower, weighed by a sharp decline in energy as oil plunged to a near-seven-year low.

  • Health-care CEOs: This is holding back the US Thursday, 3 Dec 2015 | 4:06 PM ET
    Ken Frazier, president and CEO of Merck.

    The U.S. is at a disadvantage because of this, two health-care CEOs said.

  • Dow closes down triple digits; ECB, yields eyed Thursday, 3 Dec 2015 | 4:00 PM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed sharply lower as yields climbed and traders were worried the Fed would raise rates while the economy is too weak.

  • Traders talk Barclays' bullish pharma call Tuesday, 1 Dec 2015 | 1:54 PM ET

    The "Halftime Report" traders give their top trades of the show.

  • Traders work on the floor of the New York Stock Exchange in New York City.

    U.S. stocks closed lower as investors eyed retail results and readied for key data and central bank comments later in the week.

  • U.S. stocks closed mostly higher, as gains in oil prices and energy stocks helped offset an earlier decline following news of a downed Russian jet.

  • Nov 23- Pfizer Inc's looming deal to buy Botox maker Allergan Plc for more than $150 billion will cap a record-breaking run for mergers and acquisitions in the healthcare sector, taking the cumulative value of deals in 2015 to more than $600 billion. Pfizer's tax-driven takeover of Allergan, which people familiar with the matter said won board approval on...

  • Nov 23- Pfizer Inc's looming deal to buy Botox maker Allergan Plc for more than $150 billion will cap a record-breaking run for mergers and acquisitions in the healthcare sector, taking the cumulative value of deals in 2015 to more than $600 billion. Pfizer's tax-driven takeover of Allergan, which people familiar with the matter said won board approval on...

  • Nov 20- NovoCure Ltd said its lead cancer therapy improved survival rate in brain cancer patients in combination with Avastin in a late-stage study, sending its shares up 23 percent in extended trading. NovoCure's therapy, Optune, which was evaluated in combination with Roche Holding AG's cancer drug, reduced the risk of death by 39 percent in patients, compared...